The Discounted Cash Flow (DCF) valuation of Acerus Pharmaceuticals Corporation (ASP.TO) is (131.67) CAD. With the latest stock price at 0.36 CAD, the upside of Acerus Pharmaceuticals Corporation based on DCF is -36675.8%.
Based on the latest price of 0.36 CAD and our DCF valuation, Acerus Pharmaceuticals Corporation (ASP.TO) is a sell. selling ASP.TO stocks now will result in a potential gain of 36675.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 9.5% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,460.26) - (74.90) | (131.67) |
| Upside | -405726.9% - -20906.9% | -36675.8% |